Skip to main content

Table 4 Virulence genes and genetic profile of Salmonella spp. isolates from human stool in Burkina Faso

From: Characterization of virulence factors of Salmonella isolated from human stools and street food in urban areas of Burkina Faso

Salmonella
Strain code
Ye
ar
City Source Serotypes Antigenic formule positive Identified genes Genetic profile
44 2018 Ouagadougou Human ICS OMB+ O:6,7,8 invA, fimA, stn, spvR, spvC P1
45 2018 Ouagadougou Human ICS OMA-OMB- invA, fimA, stn, spvR, spvC P1
46 2018 Ouagadougou Human ICS OMA+ O:4,5, HMB Hgm invA, fimA, stn, spvR, spvC P1
48 2018 Ouagadougou Human ICS OMB+ O:6,7,8; HMA Hi invA, fimA, stn, spvR, spvC P1
50 2018 Ouagadougou Human ICS OMB+ O:6,7,8; HMB Hg invA, fimA, stn, spvR, spvC P1
51 2018 Ouagadougou Human ICS OMA+ O:4,5; HMB Hg invA, fimA, stn, spvR, spvC P1
53 2018 Ouagadougou Human Typhimurium OMA+ O:4,5; HMA Hi; H1H2 invA, fimA, stn, spvR, spvC P1
59 2017 Ouagadougou Human ICS OMA-OMB- invA, fimA, stn, spvR, spvC P1
68 2017 Ouagadougou Human ICS OMA+ O:4,5; HMB Hg invA, fimA, stn, spvR, spvC P1
71 2018 Ouagadougou Human ICS OMA-OMB- invA, fimA, stn, spvR, spvC P1
74 2017 Koudougou Human Enteritidis OMA+ O:9; HMB Hgm invA, fimA, stn, spvR, spvC P1
75 2017 Koudougou Human Enteritidis OMA+ O:9; HMB Hgm invA, fimA, stn, spvR, spvC P1
85 2017 Ouagadougou Human ICS OMA+ O:4,5, HMB Hgm invA, fimA, stn, spvR, spvC P1
86 2017 Ouagadougou Human ICS OMA-OMB- invA, fimA, stn, spvR, spvC P1
3 2017 Bobo-Dioulasso Human Enteritidis OMA+ O:9; HMB Hgm invA, fimA, stn, spvR, spvC P1
17 2017 Ouagadougou Human ICS OMA+ O:9 invA, fimA, stn, spvR, spvC P1
18 2018 Ouagadougou Human ICS OMB+ O:6,7,8 invA, fimA, stn, spvR, spvC P1
19 2018 Ouagadougou Human ICS OMA-OMB- invA, fimA, stn, spvR, spvC P1
27 2018 Ouagadougou Human ICS OMA+ O:4,5; HMB, Hg invA, fimA, stn, spvR, spvC P1
28 2018 Ouagadougou Human ICS OMA-OMB- invA, fimA, stn, spvR, spvC P1
29 2018 Ouagadougou Human Typhimurium OMA+ O:4,5; HMA Hi; H1H2 invA, fimA, stn, spvR, spvC P1
30 2017 Ouagadougou Human ICS OMA+ O:3,10,15; HMA Hi invA, fimA, stn, spvR, spvC P1
32 2017 Ouagadougou Human ICS OMA+ O:4,5, HMB invA, fimA, stn, spvR, spvC P1
34 2017 Ouagadougou Human ICS OMA+ O:9 invA, fimA, stn, spvR, spvC P1
35 2017 Ouagadougou Human ICS OMB+ O:6,7,8; HMA Hi* invA, fimA, stn, spvR, spvC P1
36 2017 Ouagadougou Human ICS OMB+ O:6,7,8; HMA Hi* invA, fimA, stn, spvR, spvC P1
37 2017 Ouagadougou Human ICS OMA-OMB- invA, fimA, stn, spvR, spvC P1
38 2017 Ouagadougou Human ICS OMA-OMB- invA, fimA, stn, spvR, spvC P1
39 2017 Ouagadougou Human ICS OMA+ O:9 invA, fimA, stn, spvR, spvC P1
40 2017 Ouagadougou Human ICS OMA+ O:4,5, HMA invA, fimA, stn, spvR, spvC P1
43 2017 Ouagadougou Human ICS OMA+ O:4,5; HMB invA, fimA, stn, spvR, spvC P1
1 2017 Bobo-Dioulasso Human ICS OMA+ O:4,5; HMB Hg invA, fimA, stn, spvC P2
4 2017 Bobo-Dioulasso Human ICS OMA+ O:4,5; HMB,Hgm invA, fimA, stn, spvC P2
20 2018 Ouagadougou Human ICS OMB+ invA, fimA, stn, spvC P2
21 2018 Ouagadougou Human ICS OMB+ invA, fimA, stn, spvC P2
22 2018 Ouagadougou Human ICS OMA+ O:4,5, HMB invA, fimA, stn, spvC P2
23 2018 Ouagadougou Human ICS OMA-OMB- invA, fimA, stn, spvC P2
24 2018 Ouagadougou Human ICS OMA-OMB- invA, fimA, stn, spvC P2
25 2018 Ouagadougou Human ICS OMA-OMB- invA, fimA, stn, spvC P2
26 2018 Ouagadougou Human ICS OMB+ O:6,7,8 invA, fimA, stn, spvC P2
80 2017 Ouagadougou Human ICS OMB+ O:6,7,8; HMA Hi* invA, fimA, stn, spvC P2
81 2017 Ouagadougou Human ICS OMB+ O:6,7,8; HMA Hi* invA, fimA, stn, spvC P2
84 2017 Ouagadougou Human ICS OMB+ O:6,7,8; HMA Hi* invA, fimA, stn, spvC P2
2 2017 Bobo-Dioulasso Human ICS OMB+ O:6,7,8 invA, fimA, stn P3
5 2017 Bobo-Dioulasso Human ICS OMB+ invA, fimA, stn P3
6 2017 Bobo-Dioulasso Human ICS OMB+ O:6,7,8; HMA Hi* invA, fimA, stn P3
7 2017 Ouagadougou Human ICS OMA+ O:4,5; HMB,Hgm invA, fimA, stn P3
8 2017 Ouagadougou Human ICS OMB+ O:6,7,8; HMA invA, fimA, stn P3
9 2017 Ouagadougou Human ICS OMB+ O:6,7,8; HMA, Hi* invA, fimA, stn P3
10 2017 Ouagadougou Human ICS OMA+ O:4,5; HMB,H1 invA, fimA, stn P3
11 2017 Ouagadougou Human ICS OMB+ invA, fimA, stn P3
14 2017 Ouagadougou Human ICS OMA+ invA, fimA, stn P3
15 2017 Ouagadougou Human ICS OMA+ invA, fimA, stn P3
16 2017 Ouagadougou Human ICS OMA+ O:9 invA, fimA, stn P3
54 2018 Ouagadougou Human ICS OMB+ invA, fimA, stn P3
55 2018 Ouagadougou Human ICS OMA+ O:4,5; HMB Hg invA, fimA, stn P3
73 2018 Ouagadougou Human ICS OMA+ O:4,5; HMB Hg invA, fimA, stn P3
72 2017 Ouagadougou Human ICS OMB+ O:6,7,8 fimA, stn, spvC P4
13 2017 Ouagadougou Human ICS OMA+ O:4,5, HMB invA, fimA P5
31 2017 Ouagadougou Human ICS OMA-OMB- invA, fimA P5
33 2017 Ouagadougou Human ICS OMA+ O:3,10,15 invA, stn P6
58 2017 Ouagadougou Human ICS OMA+ O:4,5, HMB Hgmb fimA, stn P7
57 2017 Ouagadougou Human Enteritidis OMA+ O:9; HMB Hgm fimA, spvR P8
12 2017 Ouagadougou Human ICS OMA+ invA P9
42 2017 Ouagadougou Human ICS OMA+ O:3,10,15 fimA P10
56 2017 Ouagadougou Human Typhimurium OMA+ O:4,5; HMA Hi; H1H2 fimA P10
60 2017 Ouagadougou Human ICS OMA+ O:4,5; HMB Hg fimA P10
62 2017 Ouagadougou Human ICS OMA+ O:4,5; HMB Hg fimA P10
63 2017 Ouagadougou Human ICS OMA+ O:4,5, HMB Hgmc fimA P10
65 2017 Ouagadougou Human ICS OMA+ O:4,5; HMA Hi fimA P10
66 2017 Ouagadougou Human ICS OMB+ fimA P10
67 2017 Ouagadougou Human ICS OMA+ O:4,5, HMB Hgm fimA P10
41 2017 Ouagadougou Human ICS OMA+ O:4,5, HMB Hgm P11
47 2018 Ouagadougou Human ICS OMA-OMB- P11
49 2018 Ouagadougou Human ICS OMA+ O:3,10,15 P11
52 2018 Ouagadougou Human ICS OMA + O:3,10,15 P11
61 2017 Ouagadougou Human ICS OMA+ O:4,5; HMB P11
64 2017 Ouagadougou Human ICS OMA-OMB- P11
69 2017 Ouagadougou Human ICS OMB+ O:6,7,8; HMB Hgm P11
70 2017 Ouagadougou Human ICS OMB+ O:6,7,8; HMA Hi* P11
76 2017 Ouagadougou Human ICS OMB+ O:6,7,8; HMA Hi* P11
77 2017 Ouagadougou Human ICS OMB+ O:6,7,8; HMA Hi* P11
78 2017 Ouagadougou Human ICS OMB+ P11
79 2017 Ouagadougou Human ICS OMB+ O:6,7,8; HMA Hi* P11
82 2017 Ouagadougou Human ICS OMA+ O:4,5 P11
83 2017 Ouagadougou Human ICS OMA+ O:4,5 P11
87 2017 Ouagadougou Human ICS OMB+ P11
88 2017 Ouagadougou Human ICS OMB+ O:6,7,8 P11
89 2017 Ouagadougou Human ICS OMB+ P11
90 2017 Ouagadougou Human Enteritidis OMA+ O:9; HMB Hgm P11
91 2017 Ouagadougou Human ICS OMB+ P11
  1. ICS Incomplete serotyping, OMA Antiserum O mixture of group A, OMB Antiserum O mixture of group B, HMA Antiserum H mixture of group A, HMB Antiserum H mixture of group B; *antigenic formula (OMB+/O:6,7,8; HMA H:i) suggestive of Salmonella Kentucky/Bargny; P1: positive for all five genes tested; P2: spvR absent; P3: spvR and spvC absent; P9: unique presence of fimA; P10: unique presence of invA, P11: negative for all five genes test; a, b, c:overlapping serotypes/genetic profile